Robotic multichannel pipette device portions out blue fluid for medical and pharmaceutical research and testing.
Image Credits:David B. Gray (opens in a new window) / Getty Images

Verily is closing its medical device program as Alphabet shifts more resources to AI

Alphabet’s life sciences arm Verily laid off staff and eliminated its entire devices program Monday.

CEO Stephen Gillett announced the “difficult decision” to wind down the program in a staff memo, according to Business Insider.

“Over the years, Verily has built a legacy in developing world-class, innovative medical devices,” Gillett wrote, noting that the “path forward requires difficult decisions” as Verily refocuses on AI and data infrastructure.

The move continues Alphabet’s aggressive efforts to invest in AI while cutting costs elsewhere. The company has conducted multiple rounds of layoffs in recent years, including cuts to its HR and cloud units in February and voluntary exit programs for its more than 25,000 Platforms & Devices employees in spring.

Alphabet’s biggest recent layoffs came in January 2023, when it slashed 12,000 jobs — 6% of its workforce at the time — in anticipation of an economic slowdown.

That same month, ChatGPT became the fastest-growing consumer software application in history, gaining over 100 million users in two months and kicking off the generative AI boom that today drives the tech industry’s priorities.

Techcrunch event

Disrupt 2026: The tech ecosystem, all in one room

Your next round. Your next hire. Your next breakout opportunity. Find it at TechCrunch Disrupt 2026, where 10,000+ founders, investors, and tech leaders gather for three days of 250+ tactical sessions, powerful introductions, and market-defining innovation. Register now to save up to $400.

Save up to $300 or 30% to TechCrunch Founder Summit

1,000+ founders and investors come together at TechCrunch Founder Summit 2026 for a full day focused on growth, execution, and real-world scaling. Learn from founders and investors who have shaped the industry. Connect with peers navigating similar growth stages. Walk away with tactics you can apply immediately

Offer ends March 13.

San Francisco, CA | October 13-15, 2026

Topics

, , , ,

Latest in Biotech & Health